NCT05375279View on ClinicalTrials.gov

A PILOT Study on LSGB vs EMB in the Diagnosis of Cardiac Transthyretin Amyloidosis

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2023

Conditions
Amyloidosis
Interventions
PROCEDURE

Lip Salivary Gland Biopsy

Obtaining few salivary glands from the partipants' lip that will be studied using the Congo Red staining method.

Trial Locations (1)

N6A 5A5

London Health Sciences Centre, London

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Unity Health Toronto

OTHER

NCT05375279 - A PILOT Study on LSGB vs EMB in the Diagnosis of Cardiac Transthyretin Amyloidosis | Biotech Hunter | Biotech Hunter